The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...

Here’s news I know many readers have been anxiously awaiting: The CAR-T was a success! My 30-day and 90-day PET CTs both showed “no uptake” of the radioactive dye injected as part of the scanning ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.

CAR T-cell therapy has revolutionized treatment for many blood cancers. However, the benefits of its use in the early stages of care remain uncertain. Chimeric antigen receptor (CAR) T-cell therapy ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy ...

Chimeric antigen receptor (CAR) T cell therapy improves the detection and elimination of cancerous cells by genetically editing a patient’s immune cells to target tumor-associated antigens. This type ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

Promising advancements in CAR T-cell therapy for large B-cell lymphoma (LBCL) include potential new safety parameters, opportunities for precision care, and increased chances of achieving remission ...

Engineered CAR‑T cells suppressed HIV off medication in two people — promising but early. Larger trials are needed.